Fig. 1From: NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activityN-acetyltransferase (NAT10) is upregulated in human hepatocellular carcinoma (HCC). Immunoblotting revealed higher NAT10 protein in 14 of 19 tumor samples than in the respective matched pericancerous tissues (T, tumor; P, pericancerous tissue). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading controlBack to article page